Trial Profile
A Phase 1, Open-Label, Single-Dose Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of [14C]-PA 824 in Healthy Adult Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jun 2017
Price :
$35
*
At a glance
- Drugs Pretomanid (Primary)
- Indications Tuberculosis
- Focus Pharmacokinetics
- Acronyms CL-004
- 30 Jun 2017 New trial record